Welcome to LookChem.com Sign In|Join Free
  • or
6-chloro-2-ethyl-N-((2-(4-(trifluoromethoxy)phenyl)benzo[d]oxazol-5-yl)methyl)imidazo[1,2-a]pyridine-3-carboxamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1334718-52-3

Post Buying Request

1334718-52-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1334718-52-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1334718-52-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,3,4,7,1 and 8 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1334718-52:
(9*1)+(8*3)+(7*3)+(6*4)+(5*7)+(4*1)+(3*8)+(2*5)+(1*2)=153
153 % 10 = 3
So 1334718-52-3 is a valid CAS Registry Number.

1334718-52-3Downstream Products

1334718-52-3Relevant academic research and scientific papers

Synthesis and structure-activity relationships of novel fused ring analogues of Q203 as antitubercular agents

Kang, Sunhee,Kim, Young Mi,Jeon, Heekyung,Park, Sejin,Seo, Min Jung,Lee, Saeyeon,Park, Dongsik,Nam, Jiyeon,Lee, Seokwoo,Nam, Kiyean,Kim, Sanghee,Kim, Jaeseung

, p. 420 - 427 (2017/05/22)

A set of fused ring analogues of a new antitubercular agent, Q203, was designed and synthesized. To reduce the lipophilicity of Q203 caused by linearly extended side chains, shorter and heteroatoms containing fused rings were introduced into the side chain region. Antitubercular activity was tested against H37Rv-GFP replicating in liquid broth culture medium (extracellular) and within macrophages (intracellular). Many analogues showed potent extracellular activities as well as intracellular activities without cytotoxicity. Among them, compounds 18–21 displayed significant antitubercular activities with favorable metabolic stabilities. Representative compound 21 exhibited excellent in?vivo pharmacokinetic values at high drug exposure levels in the plasma, which makes this compound promising candidate for a new antitubercular drug.

ANTI-INFECTIVE COMPOUNDS

-

Page/Page column 94-95, (2011/10/10)

The present invention relates to small molecule compounds and their use in the treatment of bacterial infections, in particular Tuberculosis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1334718-52-3